ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 포유류 세포 배양 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 43억 7,000만 달러에서 2025년에는 48억 6,000만 달러로, CAGR 11.2%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 단일클론항체의 생산 증가, CHO 및 HEK293 세포주 이용 확대, 백신 수요 증가, 학술 및 연구소에서의 실험 활동 확대, 자가면역 및 유전 질환의 유병률 상승으로 인한 것으로 예측됩니다.
포유류 세포 배양 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년까지 73억 5,000만 달러에 달하고, CAGR은 10.9%가 될 전망입니다. 예측 기간에 있어서의 성장 요인으로는 확장성이 높은 포유류 세포 배양 시스템에 대한 주목 증가, 세포 기반 요법의 보급 확대, 임상시험에 대한 투자 증가, 바이오 의약품 제조 능력의 확충, 재조합 단백질에 대한 수요 증가 등을 들 수 있습니다. 예측 기간 동안 예상되는 주요 동향은 3D 세포 배양 기술의 진보, 바이오프로세스 최적화 혁신, 세포주 개발 진전, 자동화 및 고처리량 스크리닝의 진보, 오염 관리 및 품질 보증의 혁신을 포함합니다.
맞춤형 의료에 대한 수요 증가는 앞으로 수년간 포유류 세포 배양 시장의 성장을 이끌 것으로 예측됩니다. 맞춤형 의료는 환자의 유전적 요인, 환경 요인, 생활 습관에 따라 의료를 맞춤화하고보다 효과적이고 정밀한 치료를 제공합니다. 맞춤형 의료 수요 증가는 개인의 유전적 및 생물학적 특성에 맞춘 치료법에 의해 치료 성과를 향상시키는 능력에 기인하고 있습니다. 포유류 세포 배양은 환자 고유의 세포를 연구하기 위한 제어된 환경을 제공하고, 맞춤 치료법의 개발 및 약물 반응의 시험을 가능하게 함으로써, 개인화된 의료에서 중요한 역할을 합니다. 예를 들어 2024년 2월 미국 비영리 단체 '맞춤형 의료연합'이 발표한 바에 따르면 2023년 FDA가 희소질환 환자를 위한 신규맞춤형 치료를 16건 승인하고 2022년 6건에서 크게 증가했습니다. 그 결과, 맞춤형 의료에 대한 수요 증가가 포유류 세포 배양 시장의 성장을 가속하고 있습니다.
포유류 세포 배양 시장의 주요 기업은 단백질 수율 향상, 세포 생존율 향상, 치료 용도를 위한 확장 가능한 바이오프로세스 워크플로우의 효율화를 도모하기 위해 2성분 생산 시스템 등의 배양 배지에서의 혁신에 주력하고 있습니다. 2성분 생산 시스템은 일반적인 세포 증식을 지원하는 배지 성분과 단백질 발현을 촉진하는 배지 성분이라는 두 가지 다른 배지 성분을 사용하는 세포 배양법으로 전체적인 생산성을 향상시킵니다. 예를 들어 2023년 7월에는 스위스에 본사를 둔 수탁개발제조기관(CDMO)인 Lonza Group Ltd.가 TheraPRO CHO Media System을 발표했습니다. 이 화학적으로 정의된 동물 유래 성분이 없는 배지 시스템은 GS-CHO 포유류 세포주용으로 특별히 설계되었습니다. 본 시스템은 세포 생존율과 단백질 수율을 향상시킴으로써 치료용 단백질 및 단일클론항체의 생산성 향상을 목표로 하고 있습니다. 확장 가능한 설계는 세포주 개발에서 대규모 생산에 이르는 바이오프로세스 제조의 모든 단계를 지원합니다. Lonza는 본 제품의 도입에 의해 바이오 의약품 제조업체에서 워크플로우의 효율화, 제품 품질의 향상, 시장 투입까지의 시간 단축을 실현하는 것을 목표로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 포유류 세포 배양 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 포유류 세포 배양 시장 : 성장률 분석
세계의 포유류 세포 배양 시장 실적 : 규모와 성장, 2019-2024년
세계의 포유류 세포 배양 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 포유류 세포 배양 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 포유류 세포 배양 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
배지
혈청
시약
기기
세계의 포유류 세포 배양 시장 : 세포주별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
중국 햄스터 난소(CHO) 세포
와이스터 연구소-38(WI-38)
랫트 글리아 종양 세포주(C6)
인간 태아 신장 293세포(HEK293)
헨리에타 랙스(HeLa)
세계의 포유류 세포 배양 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
바이오 의약품 제조
백신 제조
독성시험
의약품 스크리닝 및 개발
조직 공학 및 재생 의료
세계의 포유류 세포 배양 시장 : 최종 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제약 및 생명 공학 기업
병원 및 진단실험실
연구기관 및 학술기관
수탁연구기관(CRO)
세계의 포유류 세포 배양 시장 : 배지 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
무혈청 배지
화학적으로 정의된 배지
기존 배지
무단백 배지
특수 배지
커스텀 배지 준비
세계의 포유류 세포 배양 시장 : 혈청 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
태아 소 혈청(FBS)
신생아소 혈청
성인 소 혈청
기증자 말 혈청
세계의 포유류 세포 배양 시장 : 시약 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
성장인자 및 사이토카인
세포 분산 시약
보충품 및 첨가제
동결보호제
완충액 및 염용액
항생제 및 항진균제
세계의 포유류 세포 배양 시장 : 기기 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
바이오리액터 및 발효조
배양 용기
여과 시스템
원심분리기
세포계수장치 및 분석장치
인큐베이터
바이오 세이프티 캐비닛
현미경
냉동 및 저온 보존 장치
제7장 지역별/국가별 분석
세계의 포유류 세포 배양 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 포유류 세포 배양 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
포유류 세포 배양 시장 : 경쟁 구도
포유류 세포 배양 시장 : 기업 프로파일
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
GE Healthcare : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Becton Dickinson and Company
Lonza Group AG
Avantor Inc.
Agilent Technologies Inc.
Charles river laboratories
Sartorius AG
Samsung biologics
Wuxi biologics
Bio-Techne Corporation
Miltenyi Biotec
STEMCELL Technologies
Takara Bio Inc.
Goodwin biotechnology
HiMedia Laboratories Private Limited
Promocell GmbH
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
포유류 세포 배양 시장(2029년) : 새로운 기회를 제공하는 국가
포유류 세포 배양 시장(2029년) : 새로운 기회를 제공하는 부문
포유류 세포 배양 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Mammalian cell culture is the process of growing animal cells under controlled laboratory conditions outside their natural environment. It involves maintaining cells in a nutrient-rich medium that supplies essential growth factors, gases, and conditions such as temperature and pH. This technique is widely used in research, biotechnology, and medicine for studying cell biology, producing vaccines, and testing drugs. It enables scientists to simulate in vivo conditions and observe cellular behavior in a controlled setting.
The main products used in mammalian cell culture include media, sera, reagents, and equipment. Media refers to nutrient-rich formulations designed to support the growth, proliferation, and maintenance of mammalian cells under controlled laboratory conditions. Key cell lines include Chinese hamster ovary (CHO), Wistar Institute-38 (WI-38), rat glial tumor cell line (C6), human embryonic kidney 293 (HEK293), and Henrietta Lacks (HeLa). Major applications span biopharmaceutical production, vaccine production, toxicity testing, drug screening and development, and tissue engineering and regenerative medicine, with primary end users including pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, research and academic institutes, and contract research organizations (CROs).
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The mammalian cell culture market research report is one of a series of new reports from The Business Research Company that provides mammalian cell culture market statistics, including the mammalian cell culture industry global market size, regional shares, competitors with the mammalian cell culture market share, detailed mammalian cell culture market segments, market trends, and opportunities, and any further data you may need to thrive in the mammalian cell culture industry. This mammalian cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The mammalian cell culture market size has grown rapidly in recent years. It will grow from $4.37 billion in 2024 to $4.86 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. Growth during the historic period can be attributed to the increasing production of monoclonal antibodies, the rising use of CHO and HEK293 cell lines, growing demand for vaccines, expansion of academic and research laboratory activities, and the increasing prevalence of autoimmune and genetic disorders.
The mammalian cell culture market size is expected to see rapid growth in the next few years. It will grow to $7.35 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. Growth in the forecast period can be attributed to a stronger focus on scalable mammalian cell culture systems, greater adoption of cell-based therapies, rising investment in clinical trials, expansion of biopharmaceutical manufacturing capabilities, and increasing demand for recombinant proteins. Major trends expected in the forecast period include technological advancements in 3D cell culture, innovations in bioprocess optimization, progress in cell line development, advancements in automation and high-throughput screening, and innovations in contamination control and quality assurance.
The increasing demand for personalized medicine is expected to drive the growth of the mammalian cell culture market in the coming years. Personalized medicine tailors medical treatment based on a patient's genetic, environmental, and lifestyle factors to provide more effective and precise care. The rise in demand for personalized medicine is driven by its ability to improve treatment outcomes by customizing therapies to an individual's genetic and biological profile. Mammalian cell culture plays a key role in personalized medicine by providing a controlled environment to study patient-specific cells, enabling the development of tailored therapies and testing drug responses for more accurate and effective treatments. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a significant increase from the six approved in 2022. As a result, the increasing demand for personalized medicine is fueling the growth of the mammalian cell culture market.
Leading companies in the mammalian cell culture market are focusing on innovation in cell culture media, such as two-part production systems, to improve protein yield, enhance cell viability, and streamline scalable bioprocess workflows for therapeutic applications. A two-part production system is a cell culture method that uses two distinct media components: one to support general cell growth and the other to boost protein expression, improving overall productivity. For example, in July 2023, Lonza Group Ltd., a Switzerland-based contract development and manufacturing organization (CDMO), launched the TheraPRO CHO Media System. This chemically defined, animal-component-free media system is designed specifically for GS-CHO mammalian cell lines. It aims to enhance the production of therapeutic proteins and monoclonal antibodies by improving cell viability and protein yields. Its scalable design supports all stages of bioprocess manufacturing, from cell line development to large-scale production. With this launch, Lonza seeks to streamline workflows, improve product quality, and accelerate time-to-market for biopharmaceutical manufacturers.
In December 2024, Merck KGaA, a Germany-based science and technology company, acquired HUB Organoids Holding B.V. for an undisclosed amount. This acquisition aims to advance Merck's next-generation biology portfolio by integrating HUB's organoid technology to accelerate drug discovery, expand 3D cell-culture capabilities, and provide human-relevant models for disease modeling and toxicity testing. HUB Organoids Holding B.V., based in the Netherlands, specializes in mammalian cell culture-based organoid models that replicate human organ structure and function for research and therapeutic applications.
Major companies operating in the mammalian cell culture market are Novartis AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, GE Healthcare, Becton Dickinson and Company, Lonza Group AG, Avantor Inc., Agilent Technologies Inc., Charles river laboratories, Sartorius AG, Samsung biologics, Wuxi biologics, Bio-Techne Corporation, Miltenyi Biotec, STEMCELL Technologies, Takara Bio Inc., Goodwin biotechnology, HiMedia Laboratories Private Limited, Promocell GmbH, Eppendorf AG, Cell Culture Company LLC, Cell X Technologies.
North America was the largest region in the mammalian cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mammalian cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the mammalian cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The mammalian cell culture market consists of sales of media, sera, reagents, equipment, bioreactors, culture plates, flasks, incubators, centrifuges, and microscopes. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mammalian Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on mammalian cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for mammalian cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mammalian cell culture market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Media; Sera; Reagents; Equipment
2) By Cell Line: Chinese Hamster Ovary (CHO); Wistar Institute-38 (WI-38); Rat Glial Tumor Cell Line (C6); Human Embryonic Kidney 293 (HEK293); Henrietta Lacks (HeLa)
3) By Application: Biopharmaceutical Production; Vaccine Production; Toxicity Testing; Drug Screening and Development; Tissue Engineering And Regenerative Medicine
4) By End-Use: Pharmaceutical And Biotechnology Companies; Hospitals And Diagnostic Laboratories; Research And Academic Institutes; Contract Research Organizations (CROS)
Subsegments:
1) By Media: Serum-free Media; Chemically Defined Media; Classical Media; Protein-free Media; Specialty Media; Custom Media Formulations
3) By Reagents: Growth Factors And Cytokines; Cell Dissociation Reagents; Supplements And Additives; Cryoprotective Agents; Buffers And Salt Solutions; Antibiotics And Antimycotics
4) By Equipment: Bioreactors And Fermenters; Culture Vessels; Filtration Systems; Centrifuges; Cell Counters And Analyzers; Incubators; Biosafety Cabinets; Microscopes; Refrigeration And Cryostorage Equipment
Companies Mentioned: Novartis AG; Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; GE Healthcare; Becton Dickinson and Company; Lonza Group AG; Avantor Inc.; Agilent Technologies Inc.; Charles river laboratories; Sartorius AG; Samsung biologics; Wuxi biologics; Bio-Techne Corporation; Miltenyi Biotec; STEMCELL Technologies; Takara Bio Inc.; Goodwin biotechnology; HiMedia Laboratories Private Limited; Promocell GmbH; Eppendorf AG; Cell Culture Company LLC; Cell X Technologies.
Countries:
Table of Contents
1. Executive Summary
2. Mammalian Cell Culture Market Characteristics
3. Mammalian Cell Culture Market Trends And Strategies
4. Mammalian Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Mammalian Cell Culture Growth Analysis And Strategic Analysis Framework
5.1. Global Mammalian Cell Culture PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Mammalian Cell Culture Market Growth Rate Analysis
5.4. Global Mammalian Cell Culture Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Mammalian Cell Culture Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Mammalian Cell Culture Total Addressable Market (TAM)
6. Mammalian Cell Culture Market Segmentation
6.1. Global Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Media
Sera
Reagents
Equipment
6.2. Global Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chinese Hamster Ovary (CHO)
Wistar Institute-38 (WI-38)
Rat Glial Tumor Cell Line (C6)
Human Embryonic Kidney 293 (HEK293)
Henrietta Lacks (HeLa)
6.3. Global Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biopharmaceutical Production
Vaccine Production
Toxicity Testing
Drug Screening and Development
Tissue Engineering And Regenerative Medicine
6.4. Global Mammalian Cell Culture Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Hospitals And Diagnostic Laboratories
Research And Academic Institutes
Contract Research Organizations (CROS)
6.5. Global Mammalian Cell Culture Market, Sub-Segmentation Of Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum-free Media
Chemically Defined Media
Classical Media
Protein-free Media
Specialty Media
Custom Media Formulations
6.6. Global Mammalian Cell Culture Market, Sub-Segmentation Of Sera, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fetal Bovine Serum (FBS)
Newborn Calf Serum
Adult Bovine Serum
Donor Horse Serum
6.7. Global Mammalian Cell Culture Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Growth Factors And Cytokines
Cell Dissociation Reagents
Supplements And Additives
Cryoprotective Agents
Buffers And Salt Solutions
Antibiotics And Antimycotics
6.8. Global Mammalian Cell Culture Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bioreactors And Fermenters
Culture Vessels
Filtration Systems
Centrifuges
Cell Counters And Analyzers
Incubators
Biosafety Cabinets
Microscopes
Refrigeration And Cryostorage Equipment
7. Mammalian Cell Culture Market Regional And Country Analysis
7.1. Global Mammalian Cell Culture Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Mammalian Cell Culture Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
